Buj R - Search Results

1

ATM inhibition synergizes with fenofibrate in high grade serous ovarian cancer cells.

Chen CW, Buj R, Dahl ES, Leon KE, Aird KM. Chen CW, et al. Among authors: buj r. Heliyon. 2020 Sep 29;6(9):e05097. doi: 10.1016/j.heliyon.2020.e05097. eCollection 2020 Sep. Heliyon. 2020. PMID: 33024871 Free PMC article.

2

Deoxyribonucleotide Triphosphate Metabolism in Cancer and Metabolic Disease.

Buj R, Aird KM. Buj R, et al. Front Endocrinol (Lausanne). 2018 Apr 18;9:177. doi: 10.3389/fendo.2018.00177. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 29720963 Free PMC article. Review.

3

Simultaneous isotope dilution quantification and metabolic tracing of deoxyribonucleotides by liquid chromatography high resolution mass spectrometry.

Kuskovsky R, Buj R, Xu P, Hofbauer S, Doan MT, Jiang H, Bostwick A, Mesaros C, Aird KM, Snyder NW. Kuskovsky R, et al. Among authors: buj r. Anal Biochem. 2019 Mar 1;568:65-72. doi: 10.1016/j.ab.2018.12.023. Epub 2018 Dec 31. Anal Biochem. 2019. PMID: 30605633 Free PMC article.

4

Targeting IDH1 as a Prosenescent Therapy in High-grade Serous Ovarian Cancer.

Dahl ES, Buj R, Leon KE, Newell JM, Imamura Y, Bitler BG, Snyder NW, Aird KM. Dahl ES, et al. Among authors: buj r. Mol Cancer Res. 2019 Aug;17(8):1710-1720. doi: 10.1158/1541-7786.MCR-18-1233. Epub 2019 May 20. Mol Cancer Res. 2019. PMID: 31110157 Free PMC article.

5

Suppression of p16 Induces mTORC1-Mediated Nucleotide Metabolic Reprogramming.

Buj R, Chen CW, Dahl ES, Leon KE, Kuskovsky R, Maglakelidze N, Navaratnarajah M, Zhang G, Doan MT, Jiang H, Zaleski M, Kutzler L, Lacko H, Lu Y, Mills GB, Gowda R, Robertson GP, Warrick JI, Herlyn M, Imamura Y, Kimball SR, DeGraff DJ, Snyder NW, Aird KM. Buj R, et al. Cell Rep. 2019 Aug 20;28(8):1971-1980.e8. doi: 10.1016/j.celrep.2019.07.084. Cell Rep. 2019. PMID: 31433975 Free PMC article.

6

p16: cycling off the beaten path.

Buj R, Aird KM. Buj R, et al. Mol Cell Oncol. 2019 Oct 15;6(6):e1677140. doi: 10.1080/23723556.2019.1677140. eCollection 2019. Mol Cell Oncol. 2019. PMID: 31692916 Free PMC article.

7

Suppression of p16 alleviates the senescence-associated secretory phenotype.

Buj R, Leon KE, Anguelov MA, Aird KM. Buj R, et al. Aging (Albany NY). 2021 Feb 6;13(3):3290-3312. doi: 10.18632/aging.202640. Epub 2021 Feb 6. Aging (Albany NY). 2021. PMID: 33550279 Free PMC article.

8

Loss of p16: A Bouncer of the Immunological Surveillance?

Leon KE, Tangudu NK, Aird KM, Buj R. Leon KE, et al. Among authors: buj r. Life (Basel). 2021 Apr 2;11(4):309. doi: 10.3390/life11040309. Life (Basel). 2021. PMID: 33918220 Free PMC article. Review.

9

Overexpression of oncogenic H-Ras in hTERT-immortalized and SV40-transformed human cells targets replicative and specialized DNA polymerases for depletion.

Tsao WC, Buj R, Aird KM, Sidorova JM, Eckert KA. Tsao WC, et al. Among authors: buj r. PLoS One. 2021 May 7;16(5):e0251188. doi: 10.1371/journal.pone.0251188. eCollection 2021. PLoS One. 2021. PMID: 33961649 Free PMC article.

10

DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A.

Leon KE, Buj R, Lesko E, Dahl ES, Chen CW, Tangudu NK, Imamura-Kawasawa Y, Kossenkov AV, Hobbs RP, Aird KM. Leon KE, et al. Among authors: buj r. J Cell Biol. 2021 Aug 2;220(8):e202008101. doi: 10.1083/jcb.202008101. Epub 2021 May 26. J Cell Biol. 2021. PMID: 34037658 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

25 results

Search Page

Filters